GSRCX
Price
$12.26
Change
+$0.03 (+0.25%)
Updated
Jul 10 closing price
Net Assets
408.34M
VFINX
Price
$693.80
Change
-$5.55 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

GSRCX vs VFINX

GSRCX vs VFINX Comparison Chart in %
View a ticker or compare two or three
VS
GSRCX vs. VFINX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRCX is a Buy and VFINX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.67T vs. GSRCX (408M). VFINX pays higher dividends than GSRCX: VFINX (0.97) vs GSRCX (0.60). GSRCX was incepted earlier than VFINX: GSRCX (21 years) vs VFINX (50 years). GSRCX (2.04) is less costly to investors than VFINX (0.14). GSRCX is a more actively managed with annual turnover of: 35.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than GSRCX: VFINX (0) vs GSRCX (1000). VFINX annual gain was more profitable for investors over the last year : 21.06 vs. GSRCX (2.96). VFINX return over 5 years is better than : 73.37 vs. GSRCX (-4.46).
GSRCXVFINXGSRCX / VFINX
Total Expense Ratio1.760.141,257%
Annual Report Gross Expense Ratio2.040.141,457%
Fund Existence21 years50 years-
Gain YTD11.79210.684110%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets408M1.67T0%
Annual Yield % from dividends0.600.9762%
Returns for 1 year2.9621.0614%
Returns for 3 years7.7568.3711%
Returns for 5 years-4.4673.37-6%
Returns for 10 years-35.27250.98-14%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPIX6.540.61
+10.29%
Cumberland Pharmaceuticals
BKV25.790.49
+1.94%
BKV Corp
XRTX2.03-0.02
-0.98%
XORTX Therapeutics Inc.
ORN13.35-0.38
-2.77%
Orion Group Holdings
JAZZ236.97-6.85
-2.81%
Jazz Pharmaceuticals plc